The Future of Manufacturing in an AI World: Digital Twins

i 3 Table Of Content

In 2026, many leading manufacturers are turning to AI and digital twins to improve productivity – and one of the hottest tech companies is helping to lead the charge. According to Jensen Huang, founder and CEO of NVIDIA, the world of manufacturing is currently heading toward a future where every plant will have a virtual-reality copy of their processes. NVIDIA, which produces computer chips that power AI systems, recently became the most valuable company on earth, as technology companies and Wall Street investors see them as the leading force behind the AI revolution. Manufacturers in a wide range of industries turn to NVIDIA’s AI capabilities to increase process efficiency, and Huang sees virtual plant models, or factory digital twins, as the key to future manufacturing success.

Huang says it is “very clear” that manufacturing is quickly moving in this direction, and there is significant movement toward AI tools and digital twin adoption in the biopharma industry specifically. According to Define Ventures, a venture capital firm specializing in health companies, 85% of Big Pharma leaders currently view AI as an immediate priority. When talking about digital twins during a recent talk in Washington, D.C., Huang said manufacturers should “integrate these many magnificent structures completely digitally – operate it, optimize it, and use it for planning your output completely digitally.” Huang also noted that the simulated production runs that a factory digital twin can generate will allow for testing new production features or developments before implementing them in the real world.

How the World’s Most Valuable Company Utilizes Digital Twins

For years NVIDIA has specialized in creating computer chips that are used to run AI models and produce AI software. Recently, they’ve started partnering with different organizations to support wider AI needs for their clients. For example, NVIDIA partnered with Siemens, another tech company, to create an “industrial AI operating system.” The system involves developing digital twins that virtually model and analyze the supply chains for a many different industries.

NVIDIA and Siemens’ digital twins have a wide variety of applications. For example, they created a digital twin for the city of Raleigh, which helped city leaders to make smarter infrastructure decisions that allow them to scale resources to meet demand for the area’s growing population while also ensuring adherence to safety standards.

The partners also announced work with PepsiCo earlier this year to help optimize the corporation’s manufacturing plants. NVIDIA and Siemens’ digital twins will allow PepsiCo to “simulate, validate, and optimize facility layouts before any physical build,” per the company’s press release. As a result, PepsiCo’s facilities are able to increase their total capacity. According to PepsiCo, the new digital twins have already delivered a 20% increase in throughput as well as a 10-15% reduction in capital expenditure due to uncovered capacity.

Factory Digital Twins & the Biopharma Industry in 2026

Like PepsiCo, biopharma companies have also recognized the need to strategically utilize AI to operate more efficiently and respond quickly to changes in consumer demand. In 2026, 78% of biopharma executives expect AI to play a central role in driving major change, according to Deloitte’s Life Sciences Outlook Survey. Factory digital twins have been proven to be among the best technological tools to improve production performance and optimize manufacturing processes in the biopharma industry. According to research from Clausthal University of Technology in Germany, digital twins increase operational efficiency by reducing downtime, improving resource consumption, and limiting batch-failure reduction, leading to cost savings from lower cost of goods and faster time to market.

VirtECS, a digital twin developed specifically for the biopharma industry, has been used repeatedly by major biologics facilities to help guide plant design decisions and streamline daily operations. After creating a VirtECS digital twin of their plant, biopharma companies can test possible investment ideas, changes, or improvements before implementing them in the real plant environment. As a result, VirtECS biopharma clients have been able to increase their capacity utilization, decrease plant downtime, improve run rates, and align their supply chains to adjust to delays.

While PepsiCo utilizes NVIDIA and Siemens to optimize their manufacturing facilities, VirtECS has been able to provide similar benefits to leading biopharma companies. During one project for a large biologics facility, VirtECS was used to analyze the plant’s layout and find opportunities to debottleneck processes. VirtECS’ suggested changes resulted in significant cost savings for the organization. “We reduced the necessary capital investment by $300 million by demonstrating areas where more equipment did not benefit throughput,” said the company’s senior resource planning manager.

VirtECS has also helped biopharma companies increase the capacity utilization at existing plants and during the planning processes for newly constructed facilities. As Jon Forstrom of Sanofi explained, “[VirtECS] creates a roadmap from where we are today to achieving maximum theoretical capacity.” With VirtECS supply planning capabilities, biopharma plants can maximize their profits by producing as much product as possible to meet demand forecasts. You can learn more about the unique benefits a digital twin like VirtECS can benefit biopharma plants in our short guide.

News & Insight

3 Common Myths About Factory Digital Twins

Biopharma companies setting their plans for 2027 are overwhelmingly prioritizing digital tools that can provide operational efficiency and...

The Challenges of Continuous Manufacturing for Biopharma Plants: Using Digital Twins and AI to Increase Visibility

Over the last five years, the biopharma industry has seen an increasing rate of adoption for continuous manufacturing processes. According...

Winning the Biopharma Future with an Adaptable Factory Digital Twin

Biologics products represent one of the fastest-growing sectors in the pharmaceutical industry. As biologics therapies become more...

Ready To Learn More?

Request a Discovery Call

VirtECS® software, created by Advanced Process Combinatorics, Inc. (APCI), delivers a range of capabilities built around proprietary core solver technology. This call will allow our team to gain an initial understanding of your organization’s needs and how VirtECS® can deliver results.

Complete the form and a member of our team will contact you to coordinate the most convenient option for your schedule.

 

  • This field is for validation purposes and should be left unchanged.